The solution will ‘hand-hold’ companies through the process of performing a protocol risk assessment and developing resulting quality risk management plan.
Following a long-standing working relationship between Triumph Research Intelligence (TRI) and the Metrics Champion Consortium (MCC), TRI will make MCC’s Risk Assessment and Mitigation Management Tool (RAMMT) available as part of the risk assessment and management module in its OPRA Risk-Based Monitoring and Quality Management platform. The OPRA solution will ‘hand-hold’ companies through the process of performing a protocol risk assessment and developing resulting quality risk management plan in a centrally accessible, cloud based application, and provide the guidance which comes from the MCC’s RAMMT content at the same time.
Read the full release.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.